ENDOSCOPIC AND HISTOLOGIC REMISSION AFTER 2 YEARS TREATMENT WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS

Fernando Magro  1     Laurent Peyrin-Biroulet  2     Taku Kobayashi  3     Vipul Jairath  4     Alissa Walsh  5     Britt Christensen  6     Jianmin Wu  7     Brad Dain  8     Isabel Redondo  8     Bruce E. Sands  9    
1 Centro Hospitalar São João, Porto, Portugal
2 Nancy University Hospital, Vandoeuvre-les-Nancy, France
3 Kitasato University Kitasato Institute Hospital, Minato-ku, Japan
4 Western University, London, Canada
5 NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
6 University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia
7 Eli Lilly and Company, Indianapolis, United States
8 TechData Service, King of Prussia, United States
9 Icahn School of Medicine at Mount Sinai, New York, United States

Topic
Endoscopy, Histopathology, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing